Physician profile
Gary D Harmon
NPI 1245209303
$3,212.47
in general payments reported to CMS, 2019-2025
14 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,770 · 2020: $106 · 2021: $531 · 2022: $205 · 2023: $146 · 2024: $244 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,772.88 | 2019-2021 | |
| Smith+Nephew, INC. | $487.46 | 2020-2025 | Oasis, Grafix Pl, Collagenase Santyl |
| Kci USA, INC. | $240.07 | 2019-2023 | Activ.A.C. Ion Progress, 3m Coban, Promogran Prisma |
| Abbvie INC. | $138.53 | 2021-2024 | |
| Integra Lifesciences Corporation | $129.70 | 2024-2025 | Tcc-Ez |
| Paratek Pharmaceuticals, INC. | $118.76 | 2021-2025 | Nuzyra |
| Kerecis Limited | $72.57 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Urgo Medical North America, LLC | $66.41 | 2025 | Urgoclean Ag, Urgok2 |
| Convatec INC. | $55.25 | 2021-2024 | |
| Hartmann USA, INC. | $47.61 | 2022-2023 | Zetuvit Plus |
| Aroa Biosurgery Incorporated | $23.91 | 2022 | |
| Melinta Therapeutics, LLC | $22.40 | 2024 | Kimyrsa |
| Ossur Americas, INC. | $21.81 | 2025 | |
| Bsn Medical INC | $15.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.